Case Report: Efficacy of ofatumumab in refractory anti-NMDAR encephalitis: case series and literature review
Anti-NMDAR encephalitis is the most common autoimmune encephalitis. When first-line treatments fail, second-line therapies are employed. However, a standardized approach for second-line treatment has yet to be established. We presented three cases of anti-NMDAR encephalitis with seizures and psychos...
Saved in:
| Main Authors: | Min Deng, Jing Xiong, Dan Hu, Zhaohong Kong, Tao Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1557210/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
by: Wenlin Wu, et al.
Published: (2024-12-01) -
Successful sequential treatment with ofatumumab followed by efgartigimod for refractory autoimmune encephalitis with dual anti-NMDAR and anti-GFAP antibody positivity: first case report
by: Xin Tu, et al.
Published: (2025-08-01) -
Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis
by: Min Deng, et al.
Published: (2024-11-01) -
Case Report: Anti-NMDAR encephalitis associated with neurobrucellosis: causality or coexistence?
by: Yao Wang, et al.
Published: (2025-05-01) -
Case Report: Subcutaneous ofatumumab for patients with immunosuppressant-dependent or ineffective primary membranous nephropathy
by: Jie Chen, et al.
Published: (2025-06-01)